Originally characterized at the University of Florida by the Stephen ORahilly and Robert Kraft groups, the compound has been studied in preclinical research for body composition, adipose tissue lipolysis, glucose homeostasis, skeletal muscle aging, and metabolic disease endpoints
5-Amino-1MQ inhibits NNMT activity, preserving nicotinamide for NAD+ synthesis and preserving SAM for epigenetic methylation producing a metabolic state in pre-clinical models that has been described as functionally resembling caloric restriction or elevated physical activity at the cellular level
We synthesize compounds like AOD9604 to a verifiable, high degree of purity specifically for scientists and research institutions who are studying its mechanisms of action, potential applications, and biological effects in controlled lab settings
(BOC Sciences Original) Liposomal encapsulation is the preferred choice when: You need to deliver hydrophilic copper peptides into the deeper dermis The formulation contains ingredients that might oxidize or degrade free copper ions You wish to reduce the "metallic" smell sometimes associated with high-dose copper products Controlled release is required to prevent immediate skin flushing or irritation You are developing high-value copper peptides for skin care that require visible efficacy claims Stability and color retention (blue) are critical for consumer appeal Free Copper Peptide vs
When 5-amino-1MQ preserves NAD+ levels, it enables mitochondria to produce energy more efficiently, potentially translating to improved physical performance, better recovery from exercise, and more sustained energy throughout the day
